EUVIMEDEUVIMED entdecken
Open Access

DDI–CYP: Metabolism ensemble models for drug-drug interaction predictions

Jason T Wong, Joshua S Harris, Thomas R Lane, Fabio Urbina, Sean Ekins

Drug Metabolism and Disposition · 2025

DOI: 10.1016/j.dmd.2025.100137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Jason T Wong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Collaborations Pharmaceuticals, Inc, Raleigh, North Carolina. Hauptthemen laut MEDLINE: Cytochrome P-450 Enzyme System, Models, Biological. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, NIEHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytochrome P450 (P450)-mediated drug-drug interactions (DDIs) are responsible for most adverse drug interactions, and occur when 2 concurrently administered drugs inhibit, upregulate, or are substrates of the same target enzyme. A machine learning approach enables the detection of DDIs with rarely used drugs, as well as newly approved drugs. To facilitate this, we present a framework for predicting DDIs by first predicting P450 interactions for both drugs, generating a fingerprint based on the predictions in addition to the molecular structures of the drugs, and training a machine learning model to predict the overall interaction. After optimization, the model detected potential DDIs with 85% accuracy, representing an improvement over a DDI-only model (ie, a model trained on structure-based fingerprints without supporting P450 model predictions). We also present a corresponding adverse outcome pathway to allow for increased model explainability through visualizing each predicted P450 interaction, further enhancing its real-world applicability. Finally, we show the importance of the model applicability domain to DDI models by demonstrating how the performance of our model degrades as the inference set becomes dissimilar to the training data. SIGNIFICANCE STATEMENT: Polypharmacotherapy (especially in older populations) results in more drugs prescribed concurrently, creating an increased risk of drug-drug interactions and adverse drug reactions. Computational tools to predict potential drug-drug interactions could accurately aid in reducing risk for the patient and be used in the early stages of drug design to avoid such undesirable molecular interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 Enzyme SystemModels, BiologicalDrug InteractionsHumansMachine LearningDrug-Related Side Effects and Adverse ReactionsCytochrome P-450 Enzyme InhibitorsPharmaceutical Preparations

Stichwörter der Autor:innen

Drug-drug interactionsEnsembleMachine learningP450

Substanzen

Cytochrome P-450 Enzyme SystemCytochrome P-450 Enzyme InhibitorsPharmaceutical Preparations

Autor:innen und Institutionen

  • Collaborations Pharmaceuticals, Inc, Raleigh, North Carolina.
  • Collaborations Pharmaceuticals, Inc, Raleigh, North Carolina. Electronic address: sean@collaborationspharma.com.

Förderung

  • NIEHS NIH HHS
  • NIGMS NIH HHS
  • NIEHS
  • DTRA
  • National Institutes of Health
  • NIGMS

Zitieren

APA

Wong, J. T., Harris, J. S., Lane, T. R., Urbina, F., & Ekins, S. (2025). DDI–CYP: Metabolism ensemble models for drug-drug interaction predictions. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100137

Vancouver

Wong JT, Harris JS, Lane TR, Urbina F, Ekins S. DDI–CYP: Metabolism ensemble models for drug-drug interaction predictions. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100137

BibTeX
@article{Wong2025,
  author = {Wong, Jason T and Harris, Joshua S and Lane, Thomas R and Urbina, Fabio and Ekins, Sean},
  title = {DDI–CYP: Metabolism ensemble models for drug-drug interaction predictions},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  doi = {10.1016/j.dmd.2025.100137}
}
Kostenlos starten →